CUSIP: 25459Y876
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
172,863
-
Share change
-
+39,523
-
Total reported value
-
$17,292,257
-
Put/Call ratio
-
163%
-
Price per share
-
$100.01
-
Number of holders
-
20
-
Value change
-
+$3,960,918
-
Number of buys
-
12
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 25459Y876?
CUSIP 25459Y876 identifies CURE - DIREXION SHS ETF TR - HEALTHCARE BUL in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 25459Y876:
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2023
As of 30 Jun 2023,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
172,863 shares.
The largest 10 holders included
Bullseye Investment Management, LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GTS SECURITIES LLC, GOLDMAN SACHS GROUP INC, Virtu Financial LLC, Traynor Capital Management, Inc., JANE STREET GROUP, LLC, Tower Research Capital LLC (TRC), and Onyx Bridge Wealth Group LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.